Who is this protocol a good fit for?

Anyone considering MK-677 who wants the honest evidence before discussing it with a clinician. Athletes checking WADA and anti-doping status. Readers who assumed “MK-677 supplement” meant it was a legal dietary supplement. Readers comparing oral GH secretagogues to FDA-approved GH-axis drugs like tesamorelin

What are the cautions for this protocol?

Not FDA-approved for any indication; capsules marketed as “supplements” are themselves unapproved-drug marketing under FDA's framework.. Banned at all times under WADA's anti-doping code (S2); can result in a competition ban if detected.. Merck's own Phase 2 trials documented increased appetite and reduced insulin sensitivity as real safety signals.. Educational only, not medical advice.

← Home / Peptides / YourProtocol / MK-677 (Ibutamoren): Evidence and Safety

Peptides Peptides

MK-677 (Ibutamoren): Evidence and Safety

MK-677 (Ibutamoren) is technically not a peptide, it's a small-molecule pill, but it's sold and discussed alongside injectable GH secretagogues. Merck ran Phase 2 human trials but never completed the process to seek FDA approval. Those trials documented real signals, including increased appetite and reduced insulin sensitivity, not proof that it's safe or effective for the muscle-gain, sleep, or anti-aging uses it's sold for today.

🧪

YourProtocol

YourProtocol Research

In-house · Synthesized from the cited primary sources

Daily time

5 min

Difficulty

Beginner

Sources

What the evidence says

What it is

Understand what's actually being sold

Technically not a peptide: an orally active small-molecule ghrelin-receptor agonist, popular because it's a pill rather than an injection, but stimulating the same growth-hormone and IGF-1 release pathway as injectable secretagogues.

This distinction matters for anyone assuming “peptide” marketing claims automatically apply to MK-677's chemistry.

Merck Phase 2 trial history

For this step

No product needed

Evidence tier: C

See what Merck's own trials actually found

Merck ran Phase 2 human trials for growth-hormone deficiency and hip-fracture recovery and frailty, but never submitted MK-677 for FDA approval. There is no completed RCT supporting its popular use (muscle gain, sleep, anti-aging) in healthy adults.

Real trials existing is not the same as those trials proving the popular use case works.

Merck Phase 2 trial history

For this step

No product needed

Legal status

Know where it actually stands

Not FDA-approved for any indication, not DEA-scheduled. Capsules marketed as “MK-677 supplements” are themselves illegal unapproved-drug marketing, not legal dietary supplements. A reported removal from the FDA's Category 2 list (around April 2026) is unconfirmed pending review. Banned at all times under WADA's S2 category.

“Sold as a supplement” does not make MK-677 a legal dietary supplement under FDA's framework.

FDA unapproved-drug-ingredient framework; WADA S2 list

For this step

No product needed

Safety

Know the real, trial-documented risk

Merck's own trials documented a significant increase in appetite (the basis of the frailty-trial interest) and fluid retention or edema and increased blood glucose or reduced insulin sensitivity at the doses tested. These are real, trial-derived safety signals. Unregulated-manufacturing purity risk applies to the consumer product sold online.

These signals come from Merck's own data, not from anecdote, and should be stated plainly rather than minimized.

Merck Phase 2 trial data

For this step

No product needed

What it is

MK-677 stimulates growth hormone and IGF-1 release through the ghrelin receptor, the same target as ipamorelin, but as an orally active small molecule rather than an injectable peptide. This page reports the honest evidence tier, legal status, and safety picture; it does not describe how to use it.

Why it works▼

Merck developed MK-677 and ran Phase 2 human trials, for growth-hormone deficiency and for a hip-fracture-recovery and frailty population, but never completed the process to submit it for FDA approval. Those trials exist and produced real data, but they did not lead to an approved drug, and there is no completed RCT supporting MK-677's popular use, muscle gain, sleep, anti-aging, in healthy adults. It is not FDA-approved for any indication, not a DEA-scheduled controlled substance, and sold as an unregulated research chemical; capsules marketed as “MK-677 supplements” are themselves illegal unapproved-drug marketing, not legal dietary supplements, under the FDA's general framework for unapproved drug ingredients sold as supplements. It is reported to have been removed from the FDA's Category 2 compounding list around April 2026, referred to the Pharmacy Compounding Advisory Committee for review, an unverified claim pending direct FDA.gov confirmation, the same caveat that applies to BPC-157. On WADA's list it falls under the S2 category (growth-hormone secretagogues), banned at all times in Olympic and WADA-code sport. Merck's own trials documented that MK-677 significantly increases appetite (the basis of the frailty-trial interest) and causes fluid retention or edema and increased blood glucose or reduced insulin sensitivity at the doses tested; these are real, trial-derived safety signals, not gray-market rumor. Andrew Huberman's Huberman Lab episode on peptide therapeutics groups MK-677 with ipamorelin and hexarelin as growth-hormone secretagogues, flagging the same hunger, prolactin, and REM-sleep effects for the class.

The evidence

Sources 1

Primary sources behind this page, cited straight to the source: peer-reviewed papers and reporting. Select any to view it here.

Huberman Lab: Benefits & Risks of Peptide Therapeutics for Physical & Mental Health (GH-secretagogue class segment, includes MK-677)

Article · hubermanlab.com

Source viewer

Loading the first source…

Is this for you?

Good fit if

Anyone considering MK-677 who wants the honest evidence before discussing it with a clinician
Athletes checking WADA and anti-doping status
Readers who assumed “MK-677 supplement” meant it was a legal dietary supplement
Readers comparing oral GH secretagogues to FDA-approved GH-axis drugs like tesamorelin

Cautions

Not FDA-approved for any indication; capsules marketed as “supplements” are themselves unapproved-drug marketing under FDA's framework.
Banned at all times under WADA's anti-doping code (S2); can result in a competition ban if detected.
Merck's own Phase 2 trials documented increased appetite and reduced insulin sensitivity as real safety signals.
Educational only, not medical advice.

Common questions

Is MK-677 actually a peptide?▾

No. It's a small-molecule, orally active ghrelin-receptor agonist, not a peptide, but it's sold and discussed alongside injectable GH-secretagogue peptides because it stimulates the same growth-hormone pathway.

Did Merck ever get MK-677 approved?▾

No. Merck ran Phase 2 human trials for growth-hormone deficiency and hip-fracture recovery, but never submitted it for FDA approval. It remains unapproved for any indication.

Is MK-677 a legal supplement?▾

No. It is not FDA-approved, and capsules marketed as "MK-677 supplements" are themselves illegal unapproved-drug marketing under the FDA's framework, not legal dietary supplements.

Get the next protocol first

New expert protocols and evidence updates, cited to the source. No spam; unsubscribe anytime.

Not medical advice. This page is for education only and is not a substitute for professional medical care. Consult a qualified clinician before changing your health routine.
Editorial disclosure. This protocol is written and fact-checked by the YourProtocol editorial team directly from the primary sources cited below; it is not written or reviewed by any outside expert.

MK-677 (Ibutamoren): Evidence and Safety

Read the evidence

Read it